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Abstract
The term stromal cells is referred to cells of direct or indirect (hematopoietic) mesenchymal origin, and encompasses different cell populations
residing in the connective tissue, which share the ability to produce the macromolecular components of the extracellular matrix and to organize
them in the correct spatial assembly. In physiological conditions, stromal cells are provided with the unique ability to shape a proper three-
dimensional scaffold and stimulate the growth and differentiation of parenchymal precursors to give rise to tissues and organs. Thus, stromal
cells have an essential function in the regulation of organ morphogenesis and regeneration. In pathological conditions, under the influence of
local pro-inflammatory mediators, stromal cells can be prompted to differentiate into myofibroblasts, which rather express a fibrogenic pheno-
type required for prompt deposition of reparatory scar tissue. Indeed, scarring may be interpreted as an emergency healing response to injury
typical of evolved animals, like mammals, conceivably directed to preserve survival at the expense of function. However, under appropriate con-
ditions, the original ability of stromal cells to orchestrate organ regeneration, which is typical of some lower vertebrates and mammalian
embryos, can be resumed. These concepts underline the importance of expanding the knowledge on the biological properties of stromal cells
and their role as key regulators of the three-dimensional architecture of the organs in view of the refinement of the therapeutic protocols of
regenerative medicine.
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Importance of correct three-dimensional organization of multicellular entities
Cell biologists familiar with in vitro cell cultures are well aware of the
fact that, when removed from their tissue source and adapted to in vi-
tro conditions, eukariotic cells behave as semi-amorphous organ-
isms, capable of crawling and mutually adhering to give rise to
tissue-like layers or masses, but substantially unable to form evolved
patterns of tissues and organs, although they possess all the needed
genes. In relatively limited instances, under the influence of appropri-
ate microenvironmental signals, cultured cells can re-create a tissue
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architecture resembling that of the original tissue, as occurs for autol-
ogous epidermal layers used for grafting purposes in burned patients
[1]. The mechanisms controlling the three-dimensional assembly of
cells to give rise to differentiated tissues and organs are a crucial
issue in stem cell biology as well as regenerative medicine. As a mat-
ter of fact, the odds of favourable outcome of stem cell grafting for
organ repair are reduced when the host organ has a complex three-
dimensional architecture, and even more inconsistent when this
architecture has been altered by pathological processes. At present,
widespread use of stem cell grafting for clinical purposes is only
available for non-coherent organs, such as the bone marrow, which
can be effectively and completely replaced by transplantation of
hematopoietic stem cells. On the other hand, stem cell–based treat-
ment of the failing heart can be assumed as a typical example of the
substantial inability of the regenerative approach to re-create a struc-
turally complex tissue such as the myocardium [2].
Role of extracellular matrix in
morphogenesis
The embryonic development offers us a clear paradigm of the events
and mechanisms that come into play to allow the transition from
undifferentiated rudiments to well-defined organ precursors. These
events are basically characterized by the appearance of the mesen-
chyme and, soon after, mesenchyme-derived extracellular matrix
(ECM). The functions of ECM in the embryo are numerous, but can be
resumed in the concept that ECM is capable of forming rigid, semi-
rigid and plastic structures perfectly adapted to integrate cells into
functional assemblies and regulate their differentiation, thereby deter-
mining the proper shape of the organs and the whole body. In turn,
differentiating cells are tuned to make the proper ECM molecules (col-
lagens, proteoglycans and other matrix proteins) and may switch the
type of matrix molecules they produce to meet the requirements of
time and place [3]. Moreover, by these same matrix molecules, ECM
can provide feedback information to cells, a mechanism that contrib-
utes to embryonic induction [4]. In a typical paradigm, spatiotemporal
deposition of ECM components, such as fibronectin, has been
reported to influence the correct migration of myocardial precursor
cells to form the primitive heart tube [5]. What is understood is that
ECM molecules can affect the organization of the cytoplasm via sur-
face receptors and thereby influence the shape, mobility and differen-
tiation of the cell [3, 6–8]. Indeed, the classical concept that spatially
oriented changes in cell growth, migration and differentiation are
mediated by soluble factors has been flanked by the notion that
mechanical forces contribute to morphogenesis at the same extent as
the soluble molecules [9]. In particular, through transmembrane
receptors, ECM and cell cytoskeleton are linked in an interconnected
system capable of generating and sensing the tensional forces occur-
ring in the tissue. These physical stimuli can modify cellular signal-
ling, thereby switching the cell fate [10]. In this context, mechanical
signals generated by haemodynamic stresses in the beating primitive
heart tube have been shown to play a key role in heart compartmen-
talization and valve formation [11]. Similarly, the mechanical
characteristics of the ECM can regulate self-renewal and lineage dif-
ferentiation of stem cells. For instance, mesenchymal precursors can
give rise to neuronal-like cells if grown on soft ECM, to osteoblasts
on stiff ECM and to myoblasts on ECM with intermediate stiffness
[12].
A bulk of studies have addressed the morphogenetic role of ECM,
but this goes beyond the specific object of the present article; the
reader is referred to previous, authoritative reviews for a full discus-
sion of this matter [3, 6–10].
Role of stromal cells in
morphogenesis
Mesenchymal cells are the first type of stromal cells that appear dur-
ing embryonic development. At variance with the cells of the embry-
onic sheets, such as the ectoderm and endoderm, these cells do not
express the cell–cell adhesion complexes required for epithelial cohe-
siveness, thus becoming mobile. Like mature fibroblasts, they syn-
thesize the macromolecules that compose the ECM in which they
reside. Upon further development, stromal cells with their ECM
accompany every tissue and organ. This connective tissue, or stroma,
is of pivotal importance for the final architecture and function of
organs in the mature organism [13, 14]. Of note, the many different
shapes of differentiated tissues and organs are an expression of the
shape of the ECM, which in turn was determined by stromal cells
responsible for moulding it. Using the appropriate words of Doljanski
[13], ‘it can be generalized that the ECM is the biological entity that
expresses morphology, and that (stromal) cells are the sculptors that
mould the ECM into the appropriate forms’.
The above notions underscore the primary role of mesenchyme-
derived cells in determining tissue and organ architecture. This is a
rapidly expanding field for biomedical research because of its obvious
implications for regenerative medicine. The growing knowledge in this
area has also put into evidence that stromal cells have heterogeneous
origin and features, as will be briefly sketched in the following
chapter.
Different origin of stromal cell
populations
The classical view of stromal cells as mature offspring of mesenchy-
mal precursors has been recently challenged by new knowledge
emerged from numerous studies on normal and pathological condi-
tions. Accordingly, stromal cells can be ascribed to three different
subsets: real mesenchymal, haemopoietic-derived and arisen from
epithelial–mesenchymal transition (EMT) [15]. Unfortunately,
because of the limited knowledge of their specific markers, the exact
role of each subset in the formation of stroma is neither clearly distin-
guishable nor understood. A scheme of the recognized stromal cell
lineages in the heart and their main distinctive markers is given in
Table 1. Moreover, some information comes from studies concerning
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pathological ECM formation in diseased organs, as occurs during
fibrosis, and it is not clear whether the same notions can be applied
to physiological conditions. In spite of these limitations, it is generally
accepted that all subsets can produce ECM as well as growth/differ-
entiation factors required for the build-up of stroma.
(1) Mesenchymal stromal cells are consistent with the traditional
notion of mature cells derived from mesenchymal stem cells perma-
nently residing in adult connective tissues, mainly in perivascular
niches [16, 17]. These latter cells are defined mainly by functional
assays in in vitro culture, where they display fibroblast-like features
and express numerous cell surface molecules, including Stro-1,
PDGFr, CD13, CD29, CD44, CD73, CD90, CD105 and CD146, while
lacking the markers of haematopoietic and endothelial lineages CD45
and CD31/PECAM-1 respectively [18]. Differentiation of mesenchymal
progenitors into fibroblasts is proposed to be a major source of stro-
mal cells in both normal development and fibrotic diseases [18].
However, the mesenchymal lineage can also differentiate into chon-
droblasts, osteoblasts and adipocytes [19] and may serve as peri-
cytes in the vascular wall [20]. Because of the lack of reliable
differentiation markers, the borderline between stem and mature
mesenchymal stromal cells is currently ill-defined. It has been
reported that, under non-physiological circumstances such as
hypoxia and inflammation, mesenchymal stem/stromal cells can be
mobilized to the bloodstream [21], thereby potentially contributing to
stromal cell trafficking between different connective tissue sites.
(2) Haemopoietic-derived stromal cells have been first identified
in long-term or starved leucocyte cultures as fibroblast-like cells that
retain haematopoietic and leucocytic markers (CD45, CD11b) and are
capable of secreting ECM components such as type I collagen [22].
They are thought to arise from a subset of circulating monocyte-like
cells [22, 23] and, being blood-borne mobile cells, can substantially
contribute to the stromal cell population of connective tissues [24],
especially in pathological conditions [25]. Of note, haemopoietic-
derived stromal cells have been postulated to give rise to myofibro-
blasts, the major stromal cell type involved in wound healing and
fibrotic diseases [26]. Similar to mesenchymal stromal cells, they can
also give rise to adipocytes [25, 27].
(3) Epithelial–mesenchymal transition–derived stromal cells are
originated through a peculiar morphogenetic mechanism, originally
described during embryo development, whereby epithelial cells lose
stable cell–cell and cell–basal lamina junctions and acquire the capa-
bility of migrating into the ECM [28]. This is not a mere effect of
down-regulation of attachment molecules expressed at the plasma
membrane, but involves a broader genomic reprogramming that leads
the cells to acquire a true mesenchymal differentiation, as judged by
de novo expression of vimentin, fibronectin and N-cadherin [29]. It is
currently believed that EMT is a typical stemness trait. In fact,
EMT-derived stromal cells share with mesenchymal and haemopoietic
stromal cell precursors the capability of differentiate into multiple
mesenchymal lineages, such as chondroblasts, osteoblast and adipo-
cytes [30]. Although EMT definitely plays an essential role during
embryonic development [31], its actual contribution to the normal
stromal cell population of adult organs is unknown. On the other
hand, EMT can be induced in pathological conditions, such as wound
healing, fibrosis and tumorigenesis [15].
Morpho-functional features of stromal
cells in the heart and their possible
roles
As stated in the introductory chapter, the heart is a paradigm of organ
provided with unique three-dimensional tissue architecture that is
moulded during complex organogenesis processes and is crucial to
the heart’s physiological function [32]. The cardiac stroma plays a
critical role in the maintenance of the architecture of the heart, as well
as in its pathophysiological alterations occurring in cardiac diseases,
such as for instance post-infarction remodelling and cardiac fibrosis
[33].
Cardiac fibroblasts are the most prominent and best known car-
diac stromal cell type that is held responsible for the formation and
renewal of ECM. Being differentiated cells, in the normal adult heart
their proliferative attitude is very low and presumed to be barely capa-
ble to fulfil the need for self-renewal [32]. This property is reflected in
the observation that isolated cardiac fibroblasts grow very slowly in
Table 1 Diverse cardiac stromal cell lineages and their main
markers [15, 47]
Stem cell
Early
markers
Mature
stromal cell
Late markers
Mesenchymal CD13
CD29
CD44
CD73
CD90
CD105
CD146
Stro-1
PDGFr
Fibroblast Type I collagen
Telocyte (?) CD34
CD117/c-kit
Adipocyte PPARc2
Leptin
Adiponectin
Endothelial cell CD31/PECAM-1
Haemopoietic CD45
CD11b
Fibroblast
(fibrocyte)
CD45
CD11b
Type I collagen
CD13
CD29
CD34
Myofibroblast a-SMA
Type I collagen
Adipocyte PPARc2
Leptin
Adiponectin
Endothelial cell CD31/PECAM-1
EMT-derived CD44
Vimentin
Fibronectin
n-cadherin
Fibroblast Type I collagen
Adipocyte (?) PPARc2
Leptin
Adiponectin
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culture and rapidly undergo senescence [34]. Morphologically, typical
fibroblasts can be identified in the cardiac stroma by transmission
electron microscopy. They appear as fusiform or stellate cells with
euchromatic nuclei and cytoplasms containing numerous RER pro-
files and a well-developed Golgi apparatus. Their cell surface lacks a
basal lamina and often forms grooves containing thin bundles of col-
lagen microfibrils, indicating that these cells can preside over the spa-
tial orientation of the newly formed ECM macromolecules (Fig. 1).
Besides being primarily responsible for ECM production and remodel-
ling, cardiac fibroblasts can also regulate cardiomyocyte proliferation
and growth during development through paracrine and juxtacrine sig-
nals [35–37]. Thus, they are currently viewed as a dynamic, multi-
functional lineage crucial for both developmental and post-natal repair
pathways.
In keeping with the notions highlighted in the previous chapter, in
pathological conditions, the stromal cell population of the heart can
be increased by the contribution of CD45+ haemopoietic-derived pre-
cursors, which are recruited by the injured venular endothelium
through the release of cytokines, such as monocyte chemoattractant
protein 1 (MCP-1) [38, 39]. This mechanism is thought to give rise to
the majority of reactive myofibroblasts involved in myocardial intersti-
tial fibrosis [40]. According to this view, resident mesenchymal-
derived fibroblasts are involved in reactive scarring, whereas
immigrated haemopoietic-derived (myo)fibroblasts are held responsi-
ble for adverse myocardial remodelling, characterized by excessive
collagen formation, muscle fibre entrapment, muscle atrophy, electro-
physiological abnormalities and, most commonly, abnormal cardiac
function resulting from increased ventricular stiffness and arrhyth-
mias [32]. Cardiac myofibroblasts are usually stellate cells with
euchromatic nuclei and abundant cytoplasms in which RER cisternae
and Golgi apparatus co-exist with microfilament bundles. Their
surface grooves contain coarse collagen bundles (Fig. 2).
The actual contribution of EMT to the adult population of cardiac
stromal cells in health and disease is poorly understood and matter of
investigation. This possibility is deemed plausible by similarity with
the mammalian embryo, in which cardiac fibroblasts are thought to
originate from the epithelial-like pro-epicardium via EMT [41, 42]. In
case of heart injury, a specific variant of EMT involving the coronary
vessels, termed endothelial-to-mesenchymal transition, has been
reported to take place and give rise to myofibroblasts [43].
In most recent years, a new peculiar stromal cell type has been
described and characterized in several tissues and organs, including
the heart. This has been the fortunate discovery of a talented group of
morphologists in Bucharest, Romania, led by L.M. Popescu, who
were studying the distribution in the body of interstitial cells of Cajal
(ICC), a stellate cell typically interposed between sympathetic nerve
endings and smooth muscle cells of the gastrointestinal tract.
Authentic ICC are thought to have a smooth muscular origin and to
be specifically differentiated to exert pace maker function and mediate
the neural control of visceral motility [44, 45]. While searching for
ICC in organs other than the gastrointestinal musculature, including
the pancreas, male and female reproductive tracts, gallbladder, blood
vessels and heart, Popescu and coworkers noticed a cell population
located in the interstitial stroma that was roughly similar to ICC and
expressed mesenchymal/haemopoietic lineage markers such as
CD34, CD117 and cKit. Their widespread distribution in the intersti-
tium of embryologically different organs led to hypothesize that these
cells could be a new stromal cell type. Formerly designated with the
ambiguous term ‘interstitial Cajal-like cells’, these cells are now
referred to as telocytes [46]. Their most characteristic and reliable
hallmarks are the ultrastructural features. A typical telocyte shows a
small, irregular cell body (average diameter 10 lm), containing a
nucleus with a peripheral heterochromatin rim and a scarce cyto-
plasm with a modest organellular complement. The cell periphery is
characterized by a few, very long and thin processes, termed ‘telo-
podes’, whose number determines the shape of the cell body (spindle,
triangular or stellate), and lacks a basal lamina (Fig. 3). Telocytes
have been described as a normal stromal cell population in the adult
A B
Fig. 1 Ultrastructural features of a typical
cardiac fibroblast in the swine heart epi-
cardium (A) and a high-magnification
detail (B). This cell has elongated shape,
euchromatic nucleus and cytoplasm con-
taining profiles of rough endoplasmic
reticulum (RER) and Golgi apparatus
(GA). The extracellular matrix contains
collagen fibres (CF). Collagen microfibrils
(CmF) can be seen in the proximity of the
cell surface.
4 ª 2014 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
and developing heart [47, 48]. Of note, the close relationships
between telocytes and cardiomyocytes and the apparent co-orienta-
tion of their telopodes with the longitudinal and transverse axes of the
cardiomyocytes, which takes place progressively during myocardial
development, strongly suggest that telocytes may be crucially
involved in the reported property of the cardiac stroma to mould the
three-dimensional architecture of the heart [48, 49]. Moreover, telo-
cytes have been postulated to shed microvesicles in the heart intersti-
tium [50], likely working as exosomes to carry informational
molecules, such as mRNAs [51]. This could be an additional mecha-
nism whereby telocytes may functionally modulate cardiac muscle
cells nearby. In this context, it is noteworthy that cardiac telocytes are
particularly sensitive to ischaemia and their three-dimensional net-
work in the normal heart interstitium is destroyed upon myocardial
infarction [49]. The disappearance of cardiac telocytes may concur to
explain the negligible regenerative ability of the post-infarcted heart.
At present, the exact origin and function of cardiac telocytes remains
matter of hypothesis and an area for future investigation.
Heart morphogenesis is an intricate process in which cells of dif-
ferent embryonic origin interact to ensure that the heart attains the
appropriate size, shape, tissue structure and function. In this process,
stromal cells are thought to play an important and unique task, con-
sisting in stimulating the growth and differentiation of cardiac muscle
precursors and integrating heart cells into three-dimensional func-
tional assemblies. Multiple observations from in vitro and in vivo
studies concur to support this notion. For instance: (i) telocytes have
been shown to mediate myocardial compaction from rudimental
embryonic trabeculae and regulate ventricular wall organization dur-
ing mouse heart development [48]; (ii) embryonic fibroblasts pro-
mote cardiomyocyte settlement in a three-dimensional collagen
matrix in vitro [52]; (iii) cardiac stromal cells selectively express the
cardiogenic transcriptional factor GATA-4 [53]; (iv) mesenchymal
stromal cells stimulate proliferation and differentiation of immature
cardiomyocytes [54], an effect involving Notch1/Jagged1-dependent
juxtacrine signals [37]. Of note, similar mechanisms appear to remain
active in the post-developmental heart, as judged by the findings that:
(i) in the cardiogenic niches of the adult heart, located in the epicar-
dium close to coronary artery branching [41], telocytes establish
close contacts with cardiac stem cells [55]; (ii) cardiac stromal cells
can promote the dedifferentiation and cell cycle re-entry of adult car-
diomyocytes through cell–cell contacts mediated by b-1 integrin [35].
In particular, cardiomyocyte precursors seem to require the physical
interaction with cardiac stromal cells for correct recruitment and
commitment, a mechanism that may preside over the physiological
turnover of the myocardium as well as disease-induced heart repair
[56–58]. From all these data, stromal cell/cardiomyocyte stem cell
interactions appear to be necessary for stimulating the regenerative
potential of the myocardium. This is a crucial information that can be
exploited for the design of effective stem cell–based therapeutic strat-
egies for cardiac regeneration. An additional presumptive role of car-
diac stromal cells in cardiac regeneration emerges from the
observation that these cells can be reprogrammed in vitro to differen-
tiate into cardiomyocytes [59, 60]. However, whether such repro-
gramming might spontaneously occur in the healing heart remains a
matter of speculation, as does the actual contribution of this putative
mechanism to de novo cardiac muscle formation.
Repair instead of regeneration: the
fee for evolution
Regeneration in lower vertebrates, like fishes and amphibians, is a
spectacular phenomenon by which an amputated organ grows back
A B
Fig. 2 Ultrastructural features of typical
myofibroblasts in the ventricular scar of a
post-infarcted swine heart (A). These cells
show stellate shape, euchromatic nucleus
and cytoplasm containing several cister-
nae of rough endoplasmic reticulum
(RER) and bundles of contractile microfil-
aments (asterisks). Coarse collagen fibres
(CF) adhere to the cell surface. (B) Detail
of the peripheral cytoplasm of a myofibro-
blast showing numerous RER cisternae
and an extended Golgi apparatus (GA).
Collagen microfibrils (CmF) are adjacent
to the plasma membrane and appear to
be undergoing assembly from tropocolla-
gen monomeres.
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to its original form and recovers its normal function. Among verte-
brates, the newt appears to be the most adept at replacing injured
organs, including the cardiac ventricles [61, 62]. In these species,
regeneration can occur throughout life and consists in wound closure
by de novo histogenesis that yields the reconstitution of the missing
organ. Instead, the vast majority of mammals, including humans,
respond to organ injury by a spontaneous repair process, which
closes the wound by contraction of its margins and synthesis of scar
tissue, which rather hampers regeneration of the injured tissues [63,
64]. Of note, the regenerative ability depends on the peculiar behav-
iour of mature cells near the site of injury, which are capable of losing
their differentiated characteristics and reverting to proliferating stem
cells that will later re-differentiate to replace the lost tissues [64]. This
mechanism is defined ‘cellular plasticity’ [63]. In mammals, embryos
can heal wounds spontaneously by regeneration, especially when the
injury occurs during early gestation. In foetuses and in newborns,
regeneration may take place but quickly vanishes within a few days
from birth [65]. In adults, the regenerative ability is permanently lost
or limited to superficial epithelial wounds not involving substantially
the underlying connective tissue [66]. A comprehensive analysis of
the genes and gene regulatory factors involved in cellular plasticity
has been reviewed elsewhere [63] and goes beyond the scope of this
article. However, it is worth noting that, among the events that play a
central role in the regenerative process, there is ECM remodelling
[63, 67]. Consistently with this finding, mice of the MRL strain, char-
acterized by a profound capacity for regeneration instead of scarring,
display higher MMP activity than their wild-type counterparts [68]. An
independent line of evidence indicates that a highly effective biomate-
rial that can be used to shift an injured adult organ from reparative
scarring to at least partial regeneration is a three-dimensional ECM
scaffold [64]. Such scaffolds are currently used to induce skin regen-
eration for plastic and reconstructive surgery purposes [69]. Their
mechanism of action seems to consist in the inhibition of the local
recruitment of myofibroblasts and hence wound contraction and scar-
ring [66]. Notably, ECM scaffolds display a significantly enhanced
regenerative efficacy if endowed with mesenchymal stromal cells
[70].
Conclusions
Taken together, the above notions concur to indicate that stromal
cells and ECM have an essential function in the regulation of organ
morphogenesis and regeneration. In physiological conditions, stromal
cells appear to possess the unique ability to sense the microenviron-
ment, shape a proper three-dimensional scaffold composed of their
cell bodies and elongated processes, and stimulate the growth and
differentiation of parenchymal precursors to give rise to the complex
multi-cellular assembly constituting an organ. In this context, during
embryonic development, mesenchymal cells have been found to
extend thin filopodes, 1 lm in diameter, interpreted as sensors for
spatial information necessary for correct morphogenesis [71]. Such
A B
Fig. 3 Ultrastructural features of typical
telocytes (TC) in the swine heart intersti-
tial stroma (A and B). These cells show
spindle-like shape, heterochromatic nuclei
and scarce cytoplasms containing large
cisternae of rough endoplasmic reticulum.
They are provided with extremely elon-
gated telopodes (arrows). Collagen fibres
(CF) and microfibrils (CmF) are adjacent
to the telopodes (B). The insets show
higher magnifications of the areas indi-
cated by the arrowheads.
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thin filopodes are very similar to the telopodes, the typical processes
of telocytes described in numerous developing and adult organs [46].
In pathological conditions, under the guidance of local pro-inflamma-
tory mediators, resident mesenchymal and/or haematopoietic stromal
cells recruited from the bloodstream are induced to differentiate into
myofibroblasts, which lose the capacity to behave as scaffold moul-
ders and express a fibrogenic phenotype required for prompt deposi-
tion of reparatory scar tissue [26]. From an evolutionary viewpoint,
repair by scarring could be interpreted as an emergency healing
response to injury typical of the most evolved organisms, conceivably
directed to preserve survival at the expense of function. Notwith-
standing this, a large number of reports in the literature on regenera-
tive medicine indicate that, under appropriate conditions, the original
ability of stromal cells to orchestrate organ regeneration can be
resumed. Until recently, most research efforts in regenerative medi-
cine have been focused on parenchymal stem cells, their detection
and characterization in adult organs, and their actual proliferative and
regenerative potential. The new knowledge on the biological proper-
ties of stromal cells and their fundamental role as key regulators of
the three-dimensional architecture of tissues and organs is rapidly
orienting the research towards this fascinating objective.
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